Company Gains Direct Access to Thousands of Retail Purchasing Managers From Across the Country
Deerfield Beach, Florida–(Newsfile Corp. – November 12, 2020) – CYIOS Corp. (OTC Pink: CYIO), a publicly traded company focused on developing and marketing specialty branded products in the Health and Wellness markets, is pleased to announce it has launched a wide range of My-Shield® sanitizer products including several clinically proven sanitizer products on the world class B2B retailing platform created by RangeMe. The RangeMe B2B platform provides the Company direct access to thousands of retail purchasing managers around the country, opening many doors to decision makers who would normally be difficult to reach.
John O’Shea, CYIO’s Chairman stated, “We are pleased to have launched a variety of much sought after sanitizer products including a trio of clinically proven effective sanitizer product offerings on the highly unique and expansive RangeMe B2B platform, as a verified and premium supplier. With access to over 10,000 Retail purchasing managers, the platform gives us a proven solution to get our products in front of buyers and decision makers representing retailers both large and small from across the country. Our strategy continues to be on developing market and distribution opportunities around a Triple Play of sanitizing products which have recently undergone clinical studies for effectiveness including My Shield Hand Sanitizer, Surface Cleaner and Laundry Complete. Clinical data from these studies conducted on this trio of My Shield sanitizing products have shown long lasting sanitizer protection and effectiveness against a surrogate virus for SARS-CoV-2 on skin, hard surfaces, fabrics and clothes. In working with the RangeMe team, our research indicated that there is little to no competition for our products on the RangeMe platform which is why we made the investment in resources and time. While there is some alcohol sanitizer products marketed on RangeMe, none can compete with our persistence and long-lasting effects of up to 4 hours for the hand sanitizer, up to 90 days for surface cleaner, and over 90 days for the laundry care. The company will be focusing on the Triple Play that will include the three Zetrisil®-based sanitizer products which have been most recently tested and clinically proven to be 99.9% or higher in effectiveness against a CDC recognized surrogate virus for SARS-CoV-2. Testing data has been posted on the Company’s website.”
Mr. O’Shea continued, “We believe that what sets us apart on the RangeMe platform is the ability to offer this trio of clinically tested sanitizer products which provide protection for hands/skin, surface, and clothes. Our launch on RangeMe is especially timely given pandemic cases rising globally and sanitizer solutions continuing to be a much sought after product category by businesses and consumers. The RangeMe B2B platform provides fluidity and accessibility between product suppliers and retailers with a standardized and streamlined product submission process so that retailers, both large and small, can discover new products to add into their mix.”
“Zetrisil®-based technologies are a family of proprietary silicon-based virus killing agents that reduce the presence of the virus from the hands, hard surfaces, fabric and most clothing environments. Zetrisil® effectively protects and/or ‘shields’ the area that ’24’ Brand hand sanitizer and My-Shield products are applied to from bacterial contamination. Alcohol-based hand sanitizers can be absorbed into the bloodstream, are flammable, and are only proven effective for a few minutes after each application. These factors make traditional alcohol-based hand sanitizers a less than optimal choice particularly for families with children and/or for those out and about in public. Because Zetrisil® is safer than traditional agents and remains on the skin for several hours, people are protected longer without the need for frequent applications of sanitizer ― all without the toxicity and flammability concerns of alcohol-based sanitizers. The recent clinical testing data is powerful and proven evidence of the effectiveness of these products. We believe we are well positioned to leverage the RangeMe platform and to engage directly with retail buyers representing end users such as retail consumers, small business owners and larger corporations through this triple play of sanitizing solutions providing some of the industries most powerful and effective sanitizing solutions which have now been successfully tested in clinical studies to show effectiveness against battling the current pandemic,” concluded Mr. O’Shea.
More about RangeMe: the leading online platform that streamlines new product discovery between suppliers and retailers. The platform empowers retail buyers to efficiently discover innovative and emerging products, while streamlining the inbound product submission process. For product suppliers, RangeMe enables them to grow their retail relationships with a platform that gives them the tools to manage their products, market their brand, and build awareness. Suppliers can upload full details of their products to the platform for buyers to review. In addition, suppliers know when their products are being viewed and can receive feedback from buyers, while buyers can instantly contact suppliers of interest or track a product to be alerted of updates. With buyers and suppliers better able to concentrate on finding relevant and trending products, customers benefit from a wider selection in store aisles and online.
Investors are encouraged to follow CYIOS using:
About ChoiceWellness, Inc:
ChoiceWellness, Inc. is a health and wellness company that has brought to market the DR’s CHOICE line of products, as well as the “24” Brand Hand Sanitizer products. DR’s CHOICE was developed with a mission to offer Doctors and Medical Practitioners their own Professional Grade CBD BRAND with a suite of products they could stand behind and be confident to offer to their patients. Our customers can be assured that DR’s CHOICE CBD products have gone through the highest scrutiny of testing for purity, potency and quality. DR’s Choice products have been brought to market for Doctors and Medical Professionals seeking a better solution for patients suffering from pain, inflammation, anxiety or other persistent symptoms. For more information please visit www.choicewellnessbrands.com.
About CYIOS Corporation:
CYIOS Corporation is a publicly traded company focused on developing and marketing specialty branded products in the Health and Wellness markets, including the “DR’s CHOICE” and “24” brand of products. The team has in-depth knowledge of the health and wellness markets, financial services industry, medical and health services, and blockchain. The Company looks to develop, distribute, and license proprietary products as well as evaluate potential acquisition opportunities. Further, the Company continues to seek and evaluate attractive business opportunities and to leverage its resources and expertise to build a diversified, sustainable business model. For more information please visit www.cyioscorporation.com.
FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements.” Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” & other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered w/ these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.